Trial Search Results
Responsive Neurostimulation For Loss Of Control Eating
The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.
Stanford is currently accepting patients for this trial.
Casey H. Halpern
- Device: responsive neurostimulation
- BMI 40-60 kg/m2
- Failure of at least one weight loss medication
- Previous Gastric Bypass Surgery lead to less than 50% of excess weight lost by 2 years
- Significant Loss of Control over eating
- Subject is able to attend all scheduled clinic appointments on their own or with a
- Premenopausal women must agree to use acceptable methods of birth control.
- Participants provide voluntary, decisionally capable, and appropriately informed
- Subject is able to comply w/ all testing and follow-up requirements defined by the
- Participant has no immediate plan for relocation beyond 6 hours of the study site.
- Proficiency with the English language.
- Subject has an implanted medical device that delivers electrical energy to the brain.
- Subject has an implantable cardiac pacemaker, defibrillator, or neurostimulator.
- Subject is likely to require repeat MR imaging after implant of the RNS
Neurostimulator and Leads.
- Subject is unable to fit into CT scanner (500lb upper weight limit for CT scanner).
- Inability to provide informed consent to treatment.
Ages Eligible for Study
22 Years - 65 Years
Genders Eligible for Study